top of page
Assets
NewStem
Netco Partners
Technology
Leadership
News
Investor Relations
More
Use tab to navigate through the menu items.
In The Press
Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise
Jul 13, 2023
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...
May 15, 2023
NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device
Dec 14, 2022
NovelStem Reports Third Quarter Results on Form 10-Q
Nov 14, 2022
NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...
Oct 13, 2022
NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary
Apr 11, 2022
NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset
Feb 15, 2022
NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...
Sep 28, 2021
NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator
Sep 20, 2021
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...
Dec 1, 2020
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...
Apr 21, 2020
NovelStem Provides Shareholder Update
Dec 16, 2019
NovelStem Provides Shareholder Update
May 8, 2019
Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...
Sep 25, 2018
Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...
Jul 16, 2018
bottom of page
